MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00261-021-02999-9

Медицинская библиотека · Abdominal radiology (New York) · 2021

18Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromes.

Nikpanah Moozhan, Paschall Anna K, Ahlman Mark A, Civelek Ali Cahid, Farhadi Faraz, Mirmomen S Mojdeh, Li Xiaobai, Saboury Babak, Ball Mark W, Merino Maria J, Srinivasan Ramaprasad, Jones Elizabeth C, Linehan W Marston, Malayeri Ashkan A

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

PURPOSE: To assess differences in FDG-PET/CT uptake among four subtypes of renal tumors: clear cell RCC (ccRCC), papillary type I and II RCC (pRCC), and oncocytoma.

METHODS

This retrospective study investigated 33 patients with 98 hereditary renal tumors. Lesions greater than 1 cm and patients with a timeframe of less than 18 months between preoperative imaging and surgery were considered. FDG-PET/CT images were independently reviewed by two nuclear medicine physicians, blinded to clinical information. Volumetric lesion SUVmean was measured and used to calculate a target-to-background ratio respective to liver (TBR). The Shrout-Fleiss intra-class correlation coefficient was used to assess reliability between readers. A linear mixed effects model, accounting for within-patient correlations, was used to compare TBR values of primary renal lesions with and without distant metastasis.

RESULTS

The time interval between imaging and surgery for all tumors had a median of 77 (Mean: 139; Range: 1-512) days. Intra-class reliability of mean TBR resulted in a mean κ score of 0.93, indicating strong agreement between the readers. The mixed model showed a significant difference in mean TBR among the subtypes (p < 0.0001). Pairwise comparison showed significant differences between pRCC type II and ccRCC (p < 0.0001), pRCC type II and pRCC type I (p = 0.0001), and pRCC type II and oncocytoma (p = 0.0016). Furthermore, a significant difference in FDG uptake was present between primary pRCC type II renal lesions with and without distant metastasis (p = 0.023).

CONCLUSION

pRCC type II lesions demonstrated significantly higher FDG activity than ccRCC, pRCC type I, or oncocytoma. These findings indicate that FDG may prove useful in studying the metabolic activity of renal neoplasms, identifying lesions of highest clinical concern, and ultimately optimizing active surveillance, and personalizing management plans.

Для цитирования: Nikpanah Moozhan, Paschall Anna K, Ahlman Mark A, Civelek Ali Cahid, Farhadi Faraz, Mirmomen S Mojdeh, Li Xiaobai, Saboury Babak, Ball Mark W, Merino Maria J, Srinivasan Ramaprasad, Jones Elizabeth C, Linehan W Marston, Malayeri Ashkan A. 18Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromes.. Abdominal radiology (New York). 2021. DOI: 10.1007/s00261-021-02999-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.